{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:19:07Z","timestamp":1783948747916,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Edna Foundation of Hope"},{"name":"National Institutes of Health, National Institute of Child Health and Human Development","award":["P01HD057877"],"award-info":[{"award-number":["P01HD057877"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.humpath.2017.12.005","type":"journal-article","created":{"date-parts":[[2017,12,16]],"date-time":"2017-12-16T17:58:49Z","timestamp":1513447129000},"page":"17-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["The selected biomarker analysis in 5 types of uterine smooth muscle tumors"],"prefix":"10.1016","volume":"76","author":[{"given":"Qing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaux Jenna","family":"Kanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne","family":"Ubago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dachao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise M.","family":"Scholtens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna E.","family":"Strohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Lurain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohreh","family":"Shahabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beihua","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0281-2793","authenticated-orcid":false,"given":"Jian-Jun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2017.12.005_bb0005","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/0002-9378(90)91298-Q","article-title":"Leiomyosarcoma in a series of hysterectomies performed for presumed usual-type leiomyomas","volume":"162","author":"Leibsohn","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.humpath.2017.12.005_bb0010","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0090-8258(03)00137-9","article-title":"Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy","volume":"89","author":"Giuntoli","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2017.12.005_bb0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5858\/2000-124-0221-USMT","article-title":"Uterine smooth muscle tumors: utility of classification by proliferation, ploidy, and prognostic markers versus traditional histopathology","volume":"124","author":"Layfield","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2017.12.005_bb0020","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00000478-199406000-00001","article-title":"Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases","volume":"18","author":"Bell","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2017.12.005_bb0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1542-2011.2012.00176.x","article-title":"Etiology, diagnosis, and management of usual-type leiomyomas","volume":"57","author":"Rice","year":"2012","journal-title":"J Midwifery Womens Health"},{"key":"10.1016\/j.humpath.2017.12.005_bb0030","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1518752113","article-title":"Integrated data analysis reveals usual-type leiomyoma subtypes with distinct driver pathways and biomarkers","volume":"113","author":"Mehine","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2017.12.005_bb0035","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3892\/mco.2013.124","article-title":"The biology of uterine sarcomas: a review and update","volume":"1","author":"Kobayashi","year":"2013","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.humpath.2017.12.005_bb0040","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ygyno.2004.03.017","article-title":"The protooncogene c-KIT is expressed in leiomyosarcomas of the uterus","volume":"93","author":"Raspollini","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2017.12.005_bb0045","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/PGP.0b013e318195da9f","article-title":"Fascin expression in uterine smooth muscle tumors","volume":"28","author":"Kefeli","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2017.12.005_bb0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.humpath.2016.09.014","article-title":"Myxoid leiomyosarcoma of the uterus: a clinicopathological and immunohistochemical study of 10 cases","volume":"59","author":"Lu","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2017.12.005_bb0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.yexmp.2017.01.012","article-title":"Spectrum of mutations in leiomyosarcomas identified by clinical targeted next-generation sequencing","volume":"102","author":"Lee","year":"2017","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.humpath.2017.12.005_bb0060","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/modpathol.2013.243","article-title":"MED12 and HMGA2 mutations: two independent genetic events in usual-type leiomyoma and leiomyosarcoma","volume":"27","author":"Bertsch","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2017.12.005_bb0065","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/PAS.0b013e318287779c","article-title":"Cell cycle regulatory markers in uterine atypical leiomyoma and leiomyosarcoma: immunohistochemical study of 68 cases with clinical follow-up","volume":"37","author":"Mills","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2017.12.005_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050415","article-title":"High quality genomic copy number data from archival formalin-fixed paraffin-embedded leiomyosarcoma: optimisation of universal linkage system labelling","volume":"7","author":"Salawu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2017.12.005_bb0075","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1002\/cncr.28900","article-title":"Molecular analyses of 6 different types of uterine smooth muscle tumors: emphasis in atypical leiomyoma","volume":"120","author":"Zhang","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2017.12.005_bb0080","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1158\/1078-0432.CCR-10-2050","article-title":"Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis","volume":"17","author":"Ito","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2017.12.005_bb0085","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/cncr.11586","article-title":"Differential gene expression in leiomyosarcoma","volume":"98","author":"Skubitz","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2017.12.005_bb0090","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/pgp.0b013e3180ca954f","article-title":"Differential immunoreactivity of p16 in leiomyosarcomas and leiomyoma variants","volume":"27","author":"Gannon","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2017.12.005_bb0095","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/PGP.0b013e31815ea7f5","article-title":"Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors","volume":"27","author":"Chen","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2017.12.005_bb0100","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1179\/joc.2003.15.6.596","article-title":"Estrogen and progesterone receptors expression in uterine malignant smooth muscle tumors: correlation with clinical outcome","volume":"15","author":"Raspollini","year":"2003","journal-title":"J Chemother"},{"key":"10.1016\/j.humpath.2017.12.005_bb0105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2005.05.019","article-title":"The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study","volume":"99","author":"Akhan","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2017.12.005_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-1596-7-1","article-title":"Diagnostic value of progesterone receptor and p53 expression in uterine smooth muscle tumors","volume":"7","author":"Hewedi","year":"2012","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.humpath.2017.12.005_bb0115","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ygyno.2011.11.009","article-title":"Immunohistochemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed uterine leiomyosarcoma","volume":"124","author":"Leitao","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2017.12.005_bb0120","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1053\/hupa.2001.27113","article-title":"MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors","volume":"32","author":"Mittal","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2017.12.005_bb0125","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrc3518","article-title":"Progesterone signalling in breast cancer: a neglected hormone coming into the limelight","volume":"13","author":"Brisken","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humpath.2017.12.005_bb0130","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/ajcp\/aqw030","article-title":"Progesterone receptor expression is an independent prognosticator in FIGO stage I uterine leiomyosarcoma","volume":"145","author":"Davidson","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2017.12.005_bb0135","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ygyno.2009.10.064","article-title":"Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors","volume":"116","author":"O'Cearbhaill","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2017.12.005_bb0140","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/PGP.0000000000000276","article-title":"Atypical leiomyoma with features suggesting of fumarate hydratase mutation","volume":"35","author":"Wei","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2017.12.005_bb0145","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.fertnstert.2015.09.034","article-title":"Novel fumarate hydratase mutation in a family with atypical usual-type leiomyomas and hereditary leiomyomatosis and renal cell cancer","volume":"105","author":"Wheeler","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.humpath.2017.12.005_bb0150","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/IGC.0000000000000290","article-title":"Uterine leiomyosarcoma: a review article","volume":"24","author":"Gockley","year":"2014","journal-title":"Int J Gynecol Cancer"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817717304719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817717304719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T23:14:24Z","timestamp":1617837264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817717304719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":30,"alternative-id":["S0046817717304719"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2017.12.005","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The selected biomarker analysis in 5 types of uterine smooth muscle tumors","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2017.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}